A beneficial long-term and consistent response to rituximab in the treatment of refractory neutropenia and arthritis in a patient with Felty syndrome

J Clin Rheumatol. 2014 Oct;20(7):398. doi: 10.1097/RHU.0000000000000175.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Felty Syndrome / complications
  • Felty Syndrome / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Neutropenia / drug therapy*
  • Neutropenia / etiology
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab